Microchip announces the launch of its MCP Server, an AI interface, the MCP Server connects directly with compatible AI tools ...
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback